Wet Age Related Macular Degeneration (AMD) Market Report

Global and China Wet Age Related Macular Degeneration (AMD) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 23, 2022
  • PAGES：142
  • REPORT CODE：GMM1400992
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.

    This report elaborates on the current development of the Wet Age Related Macular Degeneration (AMD) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Ophthotech Corporation

    • Kubota Pharmaceutical Holdings Co Ltd

    • Bayer AG

    • Regeneron Pharmaceuticals Inc

    • F Hoffmann-La Roche Ltd (Roche)

    • Neurotech Pharmaceuticals Inc

    • Alimera Sciences Inc

    • Gilead Sciences Inc

    • Novartis AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Lucentis

    • Eylea

    • Avastin

    Application:

    • Hospitals and Clinics

    • Research and Academic Institute

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Wet Age Related Macular Degeneration (AMD) Industry Overview

      • 1.1.1 Wet Age Related Macular Degeneration (AMD) Market Scope and Market Segments

      • 1.1.2 Wet Age Related Macular Degeneration (AMD) Industry Characteristics

      • 1.1.3 Global and China Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Wet Age Related Macular Degeneration (AMD) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Lucentis

      • 1.2.2 Eylea

      • 1.2.3 Avastin

    • 1.3 Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals and Clinics

      • 1.3.2 Research and Academic Institute

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Wet Age Related Macular Degeneration (AMD) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Wet Age Related Macular Degeneration (AMD) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Wet Age Related Macular Degeneration (AMD) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Wet Age Related Macular Degeneration (AMD) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Wet Age Related Macular Degeneration (AMD) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Wet Age Related Macular Degeneration (AMD) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Wet Age Related Macular Degeneration (AMD) Industry PEST Analysis

    • 2.3 Wet Age Related Macular Degeneration (AMD) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Wet Age Related Macular Degeneration (AMD) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Wet Age Related Macular Degeneration (AMD) Industry

    Chapter 3 Global and China Wet Age Related Macular Degeneration (AMD) Market, by Manufacturer

    • 3.1 Global and China Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Wet Age Related Macular Degeneration (AMD) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Wet Age Related Macular Degeneration (AMD) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Wet Age Related Macular Degeneration (AMD) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Wet Age Related Macular Degeneration (AMD) Market Top 3 Players

    Chapter 4 Global and China Wet Age Related Macular Degeneration (AMD) Market, by Type (2017-2028)

    • 4.1 Wet Age Related Macular Degeneration (AMD) Market Trend, by Type

    • 4.2 Global Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Wet Age Related Macular Degeneration (AMD) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Wet Age Related Macular Degeneration (AMD) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Wet Age Related Macular Degeneration (AMD) Price Trend, by Type (2017-2028)

    • 4.3 China Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Wet Age Related Macular Degeneration (AMD) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Wet Age Related Macular Degeneration (AMD) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Wet Age Related Macular Degeneration (AMD) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Wet Age Related Macular Degeneration (AMD) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Wet Age Related Macular Degeneration (AMD) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Wet Age Related Macular Degeneration (AMD) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Wet Age Related Macular Degeneration (AMD) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Wet Age Related Macular Degeneration (AMD) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Wet Age Related Macular Degeneration (AMD) Market Analysis

    • 7.1 North America Wet Age Related Macular Degeneration (AMD) Market, by Type

    • 7.2 North America Wet Age Related Macular Degeneration (AMD) Market, by Application

    • 7.3 North America Wet Age Related Macular Degeneration (AMD) Market Analysis and Forecast, by Country

      • 7.3.1 United States Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Wet Age Related Macular Degeneration (AMD) Market Analysis

    • 8.1 Europe Wet Age Related Macular Degeneration (AMD) Market, by Type

    • 8.2 Europe Wet Age Related Macular Degeneration (AMD) Market, by Application

    • 8.3 Europe Wet Age Related Macular Degeneration (AMD) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Wet Age Related Macular Degeneration (AMD) Market Analysis

    • 9.1 APAC Wet Age Related Macular Degeneration (AMD) Market, by Type

    • 9.2 APAC Wet Age Related Macular Degeneration (AMD) Market, by Application

    • 9.3 APAC Wet Age Related Macular Degeneration (AMD) Market Analysis and Forecast, by Country

      • 9.3.1 China Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Analysis

    • 10.1 Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market, by Type

    • 10.2 Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market, by Application

    • 10.3 Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Wet Age Related Macular Degeneration (AMD) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Wet Age Related Macular Degeneration (AMD) Company Profiles

      • 11.1 Ophthotech Corporation

        • 11.1.1 Ophthotech Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.1.3 Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Kubota Pharmaceutical Holdings Co Ltd

        • 11.2.1 Kubota Pharmaceutical Holdings Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Kubota Pharmaceutical Holdings Co Ltd Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.2.3 Kubota Pharmaceutical Holdings Co Ltd Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Bayer AG

        • 11.3.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Bayer AG Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.3.3 Bayer AG Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Regeneron Pharmaceuticals Inc

        • 11.4.1 Regeneron Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Regeneron Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.4.3 Regeneron Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 F Hoffmann-La Roche Ltd (Roche)

        • 11.5.1 F Hoffmann-La Roche Ltd (Roche) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 F Hoffmann-La Roche Ltd (Roche) Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.5.3 F Hoffmann-La Roche Ltd (Roche) Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Neurotech Pharmaceuticals Inc

        • 11.6.1 Neurotech Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Neurotech Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.6.3 Neurotech Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Alimera Sciences Inc

        • 11.7.1 Alimera Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Alimera Sciences Inc Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.7.3 Alimera Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Gilead Sciences Inc

        • 11.8.1 Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Gilead Sciences Inc Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.8.3 Gilead Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Novartis AG

        • 11.9.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Novartis AG Wet Age Related Macular Degeneration (AMD) Product Profiles, Application and Specification

        • 11.9.3 Novartis AG Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Wet Age Related Macular Degeneration (AMD) Industry Investment Prospect and Risk Assessment

    • 12.1 Wet Age Related Macular Degeneration (AMD) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Wet Age Related Macular Degeneration (AMD) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Production Value and Growth Rate (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Production Value and Growth Rate (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate of Lucentis (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate of Eylea (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate of Avastin (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate of Hospitals and Clinics (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate of Research and Academic Institute (2017-2028)

    • Figure North America Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Wet Age Related Macular Degeneration (AMD) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Wet Age Related Macular Degeneration (AMD) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Wet Age Related Macular Degeneration (AMD) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Wet Age Related Macular Degeneration (AMD) Market Share, by Manufacturer in 2021

    • Figure Global and China Wet Age Related Macular Degeneration (AMD) Market Share, by Manufacturer in 2022

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Volume, by Type (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Value, by Type (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Value Share, by Type (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Price Trend, by Type (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Volume, by Type (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Value, by Type (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Value Share, by Type (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Price Trend, by Type (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Volume, by Application (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Value, by Application (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Sales Value Share, by Application (2017-2028)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Sales Value Share, by Application (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Volume, by Application (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Value, by Application (2017-2028)

    • Table China Wet Age Related Macular Degeneration (AMD) Sales Value Share, by Application (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Sales Value Share, by Application (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Production, Import, Consumption and Export (2017-2022)

    • Table North America Wet Age Related Macular Degeneration (AMD) Sales Volume, by Type (2017-2028)

    • Table North America Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Figure North America Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Table North America Wet Age Related Macular Degeneration (AMD) Sales Volume, by Application (2017-2028)

    • Table North America Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure North America Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure United States Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Table Europe Wet Age Related Macular Degeneration (AMD) Sales Volume, by Type (2017-2028)

    • Table Europe Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Table Europe Wet Age Related Macular Degeneration (AMD) Sales Volume, by Application (2017-2028)

    • Table Europe Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure UK Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure France Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure France Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Table APAC Wet Age Related Macular Degeneration (AMD) Sales Volume, by Type (2017-2028)

    • Table APAC Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Table APAC Wet Age Related Macular Degeneration (AMD) Sales Volume, by Application (2017-2028)

    • Table APAC Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure India Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure India Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Wet Age Related Macular Degeneration (AMD) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Wet Age Related Macular Degeneration (AMD) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Wet Age Related Macular Degeneration (AMD) Sales Value and Growth Rate (2017-2028)

    • Table Ophthotech Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ophthotech Corporation Product Profiles, Application and Specification

    • Table Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kubota Pharmaceutical Holdings Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kubota Pharmaceutical Holdings Co Ltd Product Profiles, Application and Specification

    • Table Kubota Pharmaceutical Holdings Co Ltd Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Regeneron Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Regeneron Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Roche) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd (Roche) Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd (Roche) Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Neurotech Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Neurotech Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Neurotech Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alimera Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alimera Sciences Inc Product Profiles, Application and Specification

    • Table Alimera Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Sciences Inc Product Profiles, Application and Specification

    • Table Gilead Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Wet Age Related Macular Degeneration (AMD) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US